The overall diagnostic specificity of the test for the NAA and the healthy control was 76.32%, with a negative predictive value (NPV) of 40.28%.<h4>Conclusion</h4>NEUROG1 methylation detection can potentially be used in the CRC and AA screening. The gene discussed is NEUROG1; the disease is colorectal carcinoma.